Metabolix (MBLX) to Implementing Strategic Restructuring Making Yield10 Bioscience its Core Business
Tweet Send to a Friend
Metabolix, Inc. (NASDAQ: MBLX) announced today that it is implementing a strategic restructuring under which Yield10 Bioscience will become its ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
